Document_and_Entity_Informatio
Document and Entity Information | 6 Months Ended | |
Sep. 30, 2013 | Nov. 12, 2013 | |
Document and Entity Information: | ' | ' |
Entity Registrant Name | 'Cellular Concrete Technologies, Inc. | ' |
Document Type | '10-Q | ' |
Document Period End Date | 30-Sep-13 | ' |
Amendment Flag | 'false | ' |
Entity Central Index Key | '0001542627 | ' |
Current Fiscal Year End Date | '--03-31 | ' |
Entity Common Stock, Shares Outstanding | ' | 26,350,000 |
Entity Filer Category | 'Smaller Reporting Company | ' |
Entity Current Reporting Status | 'Yes | ' |
Entity Voluntary Filers | 'No | ' |
Entity Well-known Seasoned Issuer | 'No | ' |
Document Fiscal Year Focus | '2014 | ' |
Document Fiscal Period Focus | 'Q2 | ' |
Statement_of_Financial_Positio
Statement of Financial Position (USD $) | Sep. 30, 2013 | Mar. 31, 2013 |
Balance Sheets | ' | ' |
Accrued Liabilities, Current | $8,631 | $6,415 |
BankOverdrafts | ' | 16 |
Liabilities, Current | 8,631 | 6,431 |
Liabilities | 8,631 | 6,431 |
Common Stock, Value, Issued | 2,635 | 2,635 |
AdditionalPaidInCapital | 1,500 | 1,500 |
Accumulated Other Comprehensive Income (Loss), Net of Tax | -12,766 | -10,566 |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | ($8,631) | ($6,431) |
Statement_of_Financial_Positio1
Statement of Financial Position - Parenthetical (USD $) | Sep. 30, 2013 | Mar. 31, 2013 |
Balance Sheets | ' | ' |
Common Stock, Par Value | ($0.00) | ($0.00) |
Common Stock, Shares Authorized | 100,000,000 | 100,000,000 |
Common Stock, Shares Issued | 26,350,000 | 26,350,000 |
Common Stock, Shares Outstanding | 5,000,000 | 5,000,000 |
Statement_of_Income
Statement of Income (USD $) | 3 Months Ended | 20 Months Ended | |
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | |
Operating Expenses | ' | ' | ' |
General and Administrative Expense | $1,100 | $2,900 | $12,766 |
Operating Expenses | 1,100 | 2,900 | 12,766 |
Operating Income (Loss) | -1,100 | -2,900 | -12,766 |
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest | -1,100 | -2,900 | -12,766 |
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest | -1,100 | -2,900 | -12,766 |
Net Income (Loss) Attributable to Parent | ($1,100) | ($2,900) | ($12,766) |
Earnings Per Share | ' | ' | ' |
Earnings Per Share, Basic | $0 | $0 | ' |
Weighted Average Number of Shares Outstanding, Basic | 26,350,000 | 5,000,000 | ' |
Earnings Per Share, Diluted | $0 | $0 | ' |
Weighted Average Number of Shares Outstanding, Diluted | 26,350,000 | 5,000,000 | ' |
Statement_of_Cash_Flows
Statement of Cash Flows (USD $) | 3 Months Ended | 20 Months Ended | |
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | |
Net Cash Provided by (Used in) Operating Activities | ' | ' | ' |
Net Income (Loss) Attributable to Parent | ($1,100) | ($2,900) | ($12,766) |
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities | ' | ' | ' |
Issuance of Stock and Warrants for Services or Claims | ' | ' | 150 |
Increase (Decrease) in Operating Capital | ' | ' | ' |
Increase (Decrease) in Accrued Liabilities | 1,100 | 2,900 | 8,631 |
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities | 1,100 | 2,900 | 8,781 |
Net Cash Provided by (Used in) Operating Activities | ' | ' | -3,985 |
Net Cash Provided by (Used in) Financing Activities | ' | ' | ' |
Proceeds from Stock Plans | ' | ' | 4,335 |
Proceeds from (Payments for) Other Financing Activities | ' | ' | -350 |
Net Cash Provided by (Used in) Financing Activities | ' | ' | 3,985 |
Cash and Cash Equivalents, at Carrying Value | ' | 200 | ' |
Cash and Cash Equivalents, at Carrying Value | ' | $200 | ' |
Note_1_Organization_and_Summar
Note 1 - Organization and Summary of Significant Accounting Policies | 6 Months Ended | ||
Sep. 30, 2013 | |||
Notes | ' | ||
Note 1 - Organization and Summary of Significant Accounting Policies: | ' | ||
NOTE 1 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: | |||
(a) | Organization and Business: | ||
Cellular Concrete Technologies, Inc. (“the Company”) was incorporated in the state of Delaware on February 6, 2012 for the purpose of raising capital that is intended to be used in connection with its business plan which may include a possible merger, acquisition or other business combination with an operating business. | |||
The Company is currently in the development stage. All activities of the Company to date relate to its organization, initial funding and share issuances. | |||
(b) | Basis of Presentation- development stage and going concern | ||
The Company has not earned any revenue from operations since inception. Accordingly, the Company’s activities have been accounted for as those of a "Development Stage Enterprise" as set forth in ASC 915, "Development Stage Entities." Among the disclosures required by ASC 915, are that the Company’s financial statements be identified as those of a development stage company, and that the statements of operations, stockholders' equity and cash flows disclose activity since the date of the Company's inception. | |||
The Company sustained operating losses and accumulated deficit of $12,766 as of September 30, 2013. The Company’s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations and/or obtain additional financing, as may be required. | |||
The accompanying unaudited interim financial statements have been prepared assuming that the Company will continue as a going concern; however, the above condition raises substantial doubt about the Company’s ability to do so. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. | |||
The unaudited interim financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the audited financial statements and notes for the year ended March 31, 2013 included in our Annual Report on Form 10-K. The results of the period from inception (February 6, 2012) to September 30, 2013 are not necessarily indicative of the results to be expected for the full year ending March 31, 2014. | |||
(c) | Use of Estimates: | ||
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. | |||
(d) | Cash and Cash Equivalents | ||
For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. The Company had no cash equivalent at September 30, 2013 and March 31, 2013. | |||
(e) | Loss per Common Share | ||
Basic loss per share is calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted per share includes potentially dilutive securities such as outstanding options and warrants, using various methods such as the treasury stock or modified treasury stock method in the determination of dilutive shares outstanding during each reporting period. The Company has incurred a loss during the current period, therefore any potentially dilutive shares are excluded, as they would be anti-dilutive. The Company does not have any potentially dilutive instruments for this reporting period. | |||
(f) | Fair Value of Financial Instruments | ||
The Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 820-10, (formerly SFAS No.157), “Fair Value Measurements and Disclosures" for financial assets and liabilities. FASB ASC 820-10 provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements. FASB ASC 820-10 defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. FASB ASC 820-10 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. | |||
- | Level 1: Quoted prices in active markets for identical assets or liabilities. | ||
- | Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. | ||
- | Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. | ||
(g) | Recent Accounting Pronouncements- Adopted | ||
In May 2011, the FASB issued ASU 2011-04, "Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International Financial Reporting Standards (IFRS) of Fair Value Measurement Topic 820." ASU 2011-04 is intended to provide a consistent definition of fair value and improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with U.S. GAAP and IFRS. The amendments include those that clarify the FASB's intent about the application of existing fair value measurement and disclosure requirements, as well as those that change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. This update is effective for annual and interim periods beginning after December 15, 2011. Adoption of the new amendment did not have a material effect on the Company’s financial statements. |
Note_2_Related_Party_Transacti
Note 2 - Related Party Transactions | 6 Months Ended | |
Sep. 30, 2013 | ||
Notes | ' | |
Note 2 - Related Party Transactions | ' | |
NOTE 2 - RELATED PARTY TRANSACTIONS | ||
On September 21, 2012, Cellular Concrete Technologies, LLC. (“Purchaser”) agreed to acquire 23,350,000 shares of the Company’s common stock par value $0.0001 for a price of $0.0001 per share. At the same time, Accelerated Venture Partners, LLC agreed to tender 3,500,000 of their 5,000,000 shares of the Company’s common stock par value $0.0001 for cancellation. Following these transactions, Cellular Concrete Technologies, LLC owned approximately 94% of the Company’s 24,850,000 issued and outstanding shares of common stock par value $0.0001 and the interest of Accelerated Venture Partners, LLC was reduced to approximately 6% of the total issued and outstanding shares. Simultaneously with the share purchase, Timothy Neher resigned from the Company’s Board of Directors and Paul Falco was simultaneously appointed to the Company’s Board of Directors. Such action represents a change of control of the Company. The Purchaser used their working capital to acquire the Shares. The Purchaser did not borrow any funds to acquire the Shares. | ||
NOTE 2 - RELATED PARTY TRANSACTIONS (continued) | ||
Prior to the purchase of the shares, the Purchaser was not affiliated with the Company. However, the Purchaser will be deemed an affiliate of the Company after the share purchase as a result of their stock ownership interest in the Company. The purchase of the shares by the Purchaser was completed pursuant to written Subscription Agreements with the Company. The purchase was not subject to any other terms and conditions other than the sale of the shares in exchange for the cash payment. Concurrent with the sale of the shares, the Company will file a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware in order to change its name to “Cellular Concrete Technologies, Inc.”. | ||
On September 24, 2012, the Company entered into a Consulting Services Agreement with AVP. The agreement requires AVP to provide the Company with certain advisory services that include reviewing the Company’s business plan, identifying and introducing prospective financial and business partners, and providing general business advice regarding the Company’s operations and business strategy in consideration of (a) an option granted by the Company to AVP to purchase 1,500,000 shares of the Company’s common stock at a price of $0.0001 per share (the “AVP Option”) (which was immediately exercised by the holder) subject to a repurchase option granted to the Company to repurchase the shares at a price of $0.0001 per share in the event the Company fails to complete funding as detailed in the agreement subject to the following milestones: | ||
Milestone 1 – Company’s right of repurchase will lapse with respect to 60% of the shares upon securing $2.5 million in available cash from funding; | ||
Milestone 2 – Company’s right of repurchase will lapse with respect to 40% of the Shares upon securing $5 million in available cash (inclusive of any amounts attributable to Milestone 1); | ||
and (b) cash compensation at a rate of $12,500 per month. The payment of the cash compensation is subject to the Company’s achievement of certain designated milestones, specifically, cash compensation of $150,000 is due consultant upon the achievement of Milestone 1, and an additional $150,000 is due upon the achievement of Milestone 2. Upon achieving each Milestone, the cash compensation is to be paid to consultant in the amount then due at the rate of $12,500 per month. The total cash compensation to be received by the consultant is not to exceed $300,000 unless the Company receives an amount of funding in excess of the amount specified in Milestone 2. If the Company receives equity or debt financing that is an amount less than Milestone 1, in between any of the above Milestones or greater than the above Milestones, the cash compensation earned by the Consultant under this Agreement will be prorated according to the above Milestones. The Company also has the option to make a lump sum payment to AVP in lieu of the monthly cash payments. | ||
The sole officer and director of the Company is involved in other business activities and may, in the future, become involved in additional business opportunities that become available. A conflict may arise in selecting between the Company and other business interests. The Company has not formulated a policy for the resolution of such conflicts. | ||
We depend on our sole officer and director, to provide the Company with the necessary funds to implement our business plan, as necessary. The Company does not have a funding commitment or any written agreement for our future required cash needs. | ||
The majority shareholder has advanced funds, as necessary. These advances are considered temporary in nature and are payable on demand. There is no formal document describing the terms of this arrangement (maturity date and interest rates). As of September 30, 2013, the debts, in the amount of $6,415 was due to shareholder. | ||
The Company does not own or lease property or lease office space. The office space used by the Company was arranged by the sole officer and director of the Company to use at no charge. | ||
The above amount is not necessarily indicative of the amount that would have been incurred had a comparable transaction been entered into with independent parties. | ||
Note_3stockholders_Deficit
Note 3-stockholder's Deficit | 6 Months Ended |
Sep. 30, 2013 | |
Notes | ' |
Note 3-stockholder's Deficit | ' |
NOTE 3–STOCKHOLDER’S DEFICIT | |
The Company is currently issuing only one class of common stock, and this has been issued at two different prices since inception. The Company is authorized to issue 100,000,000 shares of common stock. As of September 30, 2013, 26,350,000 shares of common stock were issued and outstanding. | |
On February 6, 2012 (inception date), the company issued 5,000,000 shares for cash of $2,000 to the founder of the Company. | |
On September 21, 2012, Cellular Concrete Technologies, LLC. (“Purchaser”) agreed to acquire 23,350,000 shares of the Company’s common stock par value $0.0001 for a price of $0.0001 per share. At the same time, Accelerated Venture Partners, LLC agreed to tender 3,500,000 of their 5,000,000 shares of the Company’s common stock par value $0.0001 for cancellation. Following these transactions, Cellular Concrete Technologies, LLC owned approximately 94% of the Company’s 24,850,000 issued and outstanding shares of common stock par value $0.0001 and the interest of Accelerated Venture Partners, LLC was reduced to approximately 6% of the total issued and outstanding shares. Simultaneously with the share purchase, Timothy Neher resigned from the Company’s Board of Directors and Paul Falco was simultaneously appointed to the Company’s Board of Directors. Such action represents a change of control of the Company. The Purchaser used their working capital to acquire the Shares. The Purchaser did not borrow any funds to acquire the Shares. | |
Note_4_Income_Taxes
Note 4 - Income Taxes | 6 Months Ended | ||||||||
Sep. 30, 2013 | |||||||||
Notes | ' | ||||||||
Note 4 - Income Taxes | ' | ||||||||
NOTE 4 – INCOME TAXES | |||||||||
The Company has incurred net operating losses since inception. The Company has not reflected any benefit of such net operating loss carry forward in the financial statements. | |||||||||
In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. | |||||||||
Based on the level of historical taxable losses and projections of future taxable income (losses) over the periods in which the deferred tax assets can be realized, management currently believes that it is more likely than not that the Company will not realize the benefits of these deductible differences. Accordingly, the Company has provided a valuation allowance against the gross deferred tax assets as follows: | |||||||||
September 30, | March 31, | ||||||||
2013 | 2013 | ||||||||
(Unaudited) | |||||||||
Gross deferred tax assets | $ | 12,766 | $ | 10,566 | |||||
Valuation allowance | -12,766 | -10,566 | |||||||
Net deferred tax asset | $ | — | $ | — | |||||
As of September 30, 2013 the Company had a net operating loss carryforward of approximately $12,766 which will begin to in the tax year 2028. | |||||||||
Federal tax laws impose significant restrictions on the utilization of net operating loss carryforwards and research and development credits in the event of a change in ownership of the Company, as defined by the Internal Revenue Code Section 382. The Company’s net operating loss carryforwards and research and development credits may be subject to the above limitations. | |||||||||
The relevant FASB standard resulted in no adjustments to the Company’s liability for unrecognized tax benefits. As of the date of adoption and as of September 30, 2013 there were no unrecognizable tax benefits. Accordingly, a tabular reconciliation from beginning to ending periods is not provided. The Company will classify any future interest and penalties as a component of income tax expense if incurred. To date, there have been no interest or penalties charged or accrued in relation to unrecognized tax benefits. The Company is subject to federal and state examinations for the year 2013 forward. There are no tax examinations currently in progress. |
Note_1_Organization_and_Summar1
Note 1 - Organization and Summary of Significant Accounting Policies: Business Description and Basis of Presentation (Policies) | 6 Months Ended | |
Sep. 30, 2013 | ||
Policies | ' | |
Business Description and Basis of Presentation | ' | |
(a) | Organization and Business: | |
Cellular Concrete Technologies, Inc. (“the Company”) was incorporated in the state of Delaware on February 6, 2012 for the purpose of raising capital that is intended to be used in connection with its business plan which may include a possible merger, acquisition or other business combination with an operating business. | ||
The Company is currently in the development stage. All activities of the Company to date relate to its organization, initial funding and share issuances. |
Note_1_Organization_and_Summar2
Note 1 - Organization and Summary of Significant Accounting Policies: Basis of Accounting, Policy (Policies) | 6 Months Ended | |
Sep. 30, 2013 | ||
Policies | ' | |
Basis of Accounting, Policy | ' | |
(b) | Basis of Presentation- development stage and going concern | |
The Company has not earned any revenue from operations since inception. Accordingly, the Company’s activities have been accounted for as those of a "Development Stage Enterprise" as set forth in ASC 915, "Development Stage Entities." Among the disclosures required by ASC 915, are that the Company’s financial statements be identified as those of a development stage company, and that the statements of operations, stockholders' equity and cash flows disclose activity since the date of the Company's inception. | ||
The Company sustained operating losses and accumulated deficit of $12,766 as of September 30, 2013. The Company’s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations and/or obtain additional financing, as may be required. | ||
The accompanying unaudited interim financial statements have been prepared assuming that the Company will continue as a going concern; however, the above condition raises substantial doubt about the Company’s ability to do so. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. | ||
The unaudited interim financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the audited financial statements and notes for the year ended March 31, 2013 included in our Annual Report on Form 10-K. The results of the period from inception (February 6, 2012) to September 30, 2013 are not necessarily indicative of the results to be expected for the full year ending March 31, 2014. |
Note_1_Organization_and_Summar3
Note 1 - Organization and Summary of Significant Accounting Policies: Use of Estimates, Policy (Policies) | 6 Months Ended | |
Sep. 30, 2013 | ||
Policies | ' | |
Use of Estimates, Policy | ' | |
(c) | Use of Estimates: | |
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. | ||
Note_1_Organization_and_Summar4
Note 1 - Organization and Summary of Significant Accounting Policies: Cash and Cash Equivalents Disclosure (Policies) | 6 Months Ended | |
Sep. 30, 2013 | ||
Policies | ' | |
Cash and Cash Equivalents Disclosure | ' | |
(d) | Cash and Cash Equivalents | |
For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. The Company had no cash equivalent at September 30, 2013 and March 31, 2013. | ||
Note_1_Organization_and_Summar5
Note 1 - Organization and Summary of Significant Accounting Policies: Earnings Per Share, Policy (Policies) | 6 Months Ended | |
Sep. 30, 2013 | ||
Policies | ' | |
Earnings Per Share, Policy | ' | |
(e) | Loss per Common Share | |
Basic loss per share is calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted per share includes potentially dilutive securities such as outstanding options and warrants, using various methods such as the treasury stock or modified treasury stock method in the determination of dilutive shares outstanding during each reporting period. The Company has incurred a loss during the current period, therefore any potentially dilutive shares are excluded, as they would be anti-dilutive. The Company does not have any potentially dilutive instruments for this reporting period. | ||
Note_1_Organization_and_Summar6
Note 1 - Organization and Summary of Significant Accounting Policies: Fair Value Measurement, Policy (Policies) | 6 Months Ended | ||
Sep. 30, 2013 | |||
Policies | ' | ||
Fair Value Measurement, Policy | ' | ||
(f) | Fair Value of Financial Instruments | ||
The Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 820-10, (formerly SFAS No.157), “Fair Value Measurements and Disclosures" for financial assets and liabilities. FASB ASC 820-10 provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements. FASB ASC 820-10 defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. FASB ASC 820-10 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. | |||
- | Level 1: Quoted prices in active markets for identical assets or liabilities. | ||
- | Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. | ||
- | Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. | ||
Note_1_Organization_and_Summar7
Note 1 - Organization and Summary of Significant Accounting Policies: New Accounting Pronouncements and Changes in Accounting Principles (Policies) | 6 Months Ended | |
Sep. 30, 2013 | ||
Policies | ' | |
New Accounting Pronouncements and Changes in Accounting Principles | ' | |
(g) | Recent Accounting Pronouncements- Adopted | |
In May 2011, the FASB issued ASU 2011-04, "Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International Financial Reporting Standards (IFRS) of Fair Value Measurement Topic 820." ASU 2011-04 is intended to provide a consistent definition of fair value and improve the comparability of fair value measurements presented and disclosed in financial statements prepared in accordance with U.S. GAAP and IFRS. The amendments include those that clarify the FASB's intent about the application of existing fair value measurement and disclosure requirements, as well as those that change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. This update is effective for annual and interim periods beginning after December 15, 2011. Adoption of the new amendment did not have a material effect on the Company’s financial statements. |
Note_4_Income_Taxes_Schedule_o
Note 4 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables) | 6 Months Ended | ||||||||
Sep. 30, 2013 | |||||||||
Tables/Schedules | ' | ||||||||
Schedule of Deferred Tax Assets and Liabilities | ' | ||||||||
September 30, | March 31, | ||||||||
2013 | 2013 | ||||||||
(Unaudited) | |||||||||
Gross deferred tax assets | $ | 12,766 | $ | 10,566 | |||||
Valuation allowance | -12,766 | -10,566 | |||||||
Net deferred tax asset | $ | — | $ | — |
Note_4_Income_Taxes_Schedule_o1
Note 4 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) (USD $) | Sep. 30, 2013 | Mar. 31, 2013 |
Details | ' | ' |
Deferred Tax Assets, Gross | $12,766 | $10,566 |
Valuation Allowance, Amount | ($12,766) | ($10,566) |